Greenstone Biosciences And Intel Collaborate To Accelerate AI Driven Drug Discovery

Big pharma just showed every business owner something important about AI adoption. And most people completely missed it. You've probably been there — bought a tool, paid the monthly fee, watched yo

Big pharma just showed every business owner something important about AI adoption.

And most people completely missed it.


You've probably been there — bought a tool, paid the monthly fee, watched your team ignore it. That "$200/month wasted" feeling is real. It's not because you picked wrong. It's because nobody told you the actual rule.


Greenstone Biosciences and Intel didn't just plug in an AI tool and hope. They started with one specific problem — analyzing human cell data to find drug candidates faster. Then they matched the right infrastructure to that exact problem.

That's the whole secret. AI works when it's pointed at one clearly defined bottleneck in your business. Not "improve everything." One thing.

Most consultants skip this step. They sell you capability. Nobody sells you clarity.


Here's what you can do this week without touching a single existing system: Write down the one task your team repeats most that produces the least value. That's your AI starting point. One problem, one tool, one measurable result within 30 days.

That's how the wins actually start.


What's the one repetitive task in your business you wish you could hand off tomorrow — and have you tried using AI for it yet?

#AIStrategy #SmallBusiness #AIImplementation #BusinessGrowth

Original Source

The collaboration combines Greenstone's large scale human iPSC biobank with Intel's Edge AI computing infrastructure to advance precision medicine ...